JP2015504066A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504066A5
JP2015504066A5 JP2014550770A JP2014550770A JP2015504066A5 JP 2015504066 A5 JP2015504066 A5 JP 2015504066A5 JP 2014550770 A JP2014550770 A JP 2014550770A JP 2014550770 A JP2014550770 A JP 2014550770A JP 2015504066 A5 JP2015504066 A5 JP 2015504066A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutical composition
composition according
pathological condition
metal complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014550770A
Other languages
English (en)
Japanese (ja)
Other versions
JP6131271B2 (ja
JP2015504066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/056959 external-priority patent/WO2013102806A1/en
Publication of JP2015504066A publication Critical patent/JP2015504066A/ja
Publication of JP2015504066A5 publication Critical patent/JP2015504066A5/ja
Application granted granted Critical
Publication of JP6131271B2 publication Critical patent/JP6131271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014550770A 2012-01-05 2012-12-04 カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 Active JP6131271B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261583377P 2012-01-05 2012-01-05
US61/583,377 2012-01-05
US201261656178P 2012-06-06 2012-06-06
US61/656,178 2012-06-06
US201261668679P 2012-07-06 2012-07-06
US61/668,679 2012-07-06
US201261721575P 2012-11-02 2012-11-02
US61/721,575 2012-11-02
PCT/IB2012/056959 WO2013102806A1 (en) 2012-01-05 2012-12-04 Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017081176A Division JP6316479B2 (ja) 2012-01-05 2017-04-17 カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法

Publications (3)

Publication Number Publication Date
JP2015504066A JP2015504066A (ja) 2015-02-05
JP2015504066A5 true JP2015504066A5 (https=) 2016-01-28
JP6131271B2 JP6131271B2 (ja) 2017-05-17

Family

ID=47559596

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014550770A Active JP6131271B2 (ja) 2012-01-05 2012-12-04 カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法
JP2017081176A Active JP6316479B2 (ja) 2012-01-05 2017-04-17 カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017081176A Active JP6316479B2 (ja) 2012-01-05 2017-04-17 カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法

Country Status (15)

Country Link
US (3) US9187509B2 (https=)
EP (1) EP2800755B1 (https=)
JP (2) JP6131271B2 (https=)
KR (1) KR102086022B1 (https=)
CN (2) CN107353313B (https=)
AU (1) AU2012364227B2 (https=)
BR (1) BR112014016497B1 (https=)
CA (1) CA2862736C (https=)
ES (1) ES2683038T3 (https=)
HK (1) HK1245276B (https=)
IN (1) IN2014MN01495A (https=)
MX (1) MX2014008247A (https=)
RU (2) RU2622646C2 (https=)
WO (1) WO2013102806A1 (https=)
ZA (1) ZA201404904B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9187509B2 (en) 2012-01-05 2015-11-17 Pled Pharma AB Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment
KR20150080616A (ko) * 2012-11-02 2015-07-09 플레드파르마 에이비 암 치료 방법
US10233205B2 (en) 2015-08-07 2019-03-19 Auburn University Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
EP3402475B1 (en) 2016-01-11 2021-10-20 Egetis Therapeutics AB Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions
CN110139673B (zh) * 2016-11-14 2022-03-22 卡尔森图纳投资公司 使用非过渡金属配位的二吡哆基化合物以预防和治疗化疗诱发的psn
CN117279657A (zh) 2021-05-18 2023-12-22 日本株式会社Ltt生物医药 用于治疗或预防伴随抗癌剂给药的障碍的医药组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223243A (en) 1987-05-08 1993-06-29 Salutar, Inc. Dipyridoxyl phosphate chelating compound intermediates useful as NMRI contrast agents
AR246956A1 (es) * 1987-05-08 1994-10-31 Salutar Inc Compuesto quelante, un intermediario para preparar el mismo, y un procedimiento para preparar una composicion de medio de contraste.
US5091169A (en) 1987-05-08 1992-02-25 Salutar, Inc. Dipyridoxyl phosphate NMRI contrast agent compositions
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6204259B1 (en) 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
GB9613182D0 (en) * 1996-06-24 1996-08-28 Nycomed Imaging As Method
GB9727224D0 (en) 1997-12-23 1998-02-25 Nycomed Imaging As Method
AU1770299A (en) 1997-12-23 1999-07-19 Nycomed Imaging As Nitric oxide releasing chelating agents and their therapeutic use
FR2823977B1 (fr) 2001-04-26 2006-12-01 Univ Rene Descartes Utilisation du mangafodipir dans le traitement des effets d'un stress oxydatif
DE10359628A1 (de) 2003-12-18 2005-07-21 Oxeno Olefinchemie Gmbh Katalysator und Verfahren zur Herstellung von 1-Olefinen aus 2-Hydroxyalkanen
US20070148154A1 (en) 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
BRPI0820832A2 (pt) * 2007-12-14 2015-06-16 Pledpharma Ab Composto, uso de um composto, método de tratamento de câncer, composição farmacêutica, kit , e, uso de uma composição farmacêutica.
US8414866B2 (en) * 2007-12-17 2013-04-09 Ge Healthcare As Method of magnetic resonance imaging of the heart with paramagnetic MN2+
CN102481295A (zh) * 2009-07-06 2012-05-30 普莱制药公司 利用锰配合物化合物与所述化合物之非锰配合物形式的组合的药物组合物和治疗方法
US9187509B2 (en) * 2012-01-05 2015-11-17 Pled Pharma AB Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment

Similar Documents

Publication Publication Date Title
JP2015504066A5 (https=)
US6391895B1 (en) Nitric oxide releasing chelating agents and their therapeutic use
RU2014132184A (ru) Калмангафодипир, новое химическое соединение и другие смешанные комплексные соединения с металлами, способы получения, композиции и способы лечения
CN102343099B (zh) 叶酸介导的肿瘤靶向阿霉素前体药物的制备及其应用
US20160271116A1 (en) Polyethylene glycol-cactus oligopeptide bonding rapamycin derivatives
US8809562B2 (en) Use of metallocene compounds for cancer treatment
HK1245276A1 (en) Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment
RU2012103889A (ru) Фармацевтические композиции и терапевтические способы, в которых применяется комбинация комплексного соединения марганца и соединения в форме, не являющейся марганцевым комплексом
US20240100066A1 (en) ORAL Pt (IV) ANTICANCER PRODRUG CONTAINING 3-BROMOPYRUVATE AS AXIAL LIGAND
CN105396142B (zh) 人血清白蛋白‑药物复合物及其合成方法和应用
KR101678865B1 (ko) 암의 치료에 사용하기 위한 화합물들
Barbara et al. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
WO2011008132A1 (ru) Низкомолекулярные модуляторы фармакологической активности
JP6021847B2 (ja) 扁平上皮ガン及び肝ガンの抑制剤とされるスチルベノイド化合物及びその用途
US20150313921A1 (en) Cancer Treatment Methods
CN102746316A (zh) 用于抗肿瘤药物的间硝基芳甲氧基喜树碱缺氧激活前药
Hasan Copper (II) Complexes as Potential Anti-Cancer Agents Compared to Cisplatin
JP7065866B2 (ja) 化学療法で誘発されたpsnを防止および処置するための非遷移金属配位ジピリドキシル化合物の使用
HK1151971B (en) Compounds for use in the treatment of cancer
EP3655414A1 (en) Deferoxamine derivatives as medicaments
HK1203203B (en) Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment